Alpine Associates Management’s Intersect ENT, Inc XENT Stock Holding History

Alpine Associates Management’s Portfolio XENT Stock Details XENT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-1,384,262	Closed	-$38.8M	–	61
2022 Q1	$38.8M	Sell	1,384,262 -30,338	-2%	-$831K	1.66%	21
2021 Q4	$38.6M	Buy	1,414,600 +21,600	+2%	+$585K	1.45%	19
2021 Q3	$37.9M	Buy	+1,393,000	New	+$34.4M	1.23%	29

Alpine Associates Management's XENT Position: Q2 2022 in Review

Alpine Associates Management sold out of Intersect ENT, Inc (XENT) in Q2 2022, closing a stake of 1,384,262 shares — an estimated $38.8M sold.

Alpine Associates Management first reported a position in XENT in Q3 2021 and held it in 3 quarters. The position peaked at $38.8M in Q1 2022. 0 funds tracked by Wall St. Rank hold XENT as of Q2 2022.

Alpine Associates Management reported no remaining Intersect ENT, Inc position as of Q2 2022 after selling out during the quarter.
Alpine Associates Management sold 1,384,262 Intersect ENT, Inc shares in Q2 2022, an estimated $38.8M.
Alpine Associates Management first reported a position in Intersect ENT, Inc in Q3 2021 and held it in 3 quarters.
Alpine Associates Management's Intersect ENT, Inc position peaked at $38.8M in Q1 2022.
0 funds tracked by Wall St. Rank held Intersect ENT, Inc as of Q2 2022.

Based on Alpine Associates Management's 13F filing for Q2 2022, filed 9 Aug 2022.